Xenon Pharmaceuticals Inc (XENE)
43.75
+0.75
(+1.74%)
USD |
NASDAQ |
May 03, 16:00
43.75
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Free Cash Flow: -150.94M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -150.94M |
| September 30, 2023 | -149.88M |
| June 30, 2023 | -137.24M |
| March 31, 2023 | -119.30M |
| December 31, 2022 | -101.32M |
| September 30, 2022 | -88.06M |
| June 30, 2022 | -72.51M |
| March 31, 2022 | -69.08M |
| December 31, 2021 | -71.55M |
| September 30, 2021 | -64.27M |
| June 30, 2021 | -60.99M |
| March 31, 2021 | -58.16M |
| December 31, 2020 | -50.76M |
| September 30, 2020 | -17.63M |
| June 30, 2020 | -12.78M |
| March 31, 2020 | -10.64M |
| December 31, 2019 | -5.954M |
| September 30, 2019 | -32.56M |
| June 30, 2019 | -39.20M |
| Date | Value |
|---|---|
| March 31, 2019 | -35.86M |
| December 31, 2018 | -35.23M |
| September 30, 2018 | -34.72M |
| June 30, 2018 | -29.62M |
| March 31, 2018 | -30.84M |
| December 31, 2017 | -29.04M |
| September 30, 2017 | -26.84M |
| June 30, 2017 | -22.77M |
| March 31, 2017 | -21.42M |
| December 31, 2016 | -19.85M |
| September 30, 2016 | -20.54M |
| June 30, 2016 | -21.07M |
| March 31, 2016 | -18.05M |
| December 31, 2015 | -18.65M |
| September 30, 2015 | -16.99M |
| June 30, 2015 | -5.86M |
| March 31, 2015 | -5.572M |
| December 31, 2014 | -1.263M |
Free Cash Flow Range, Past 5 Years
-150.94M
Minimum
Dec 2023
-5.954M
Maximum
Dec 2019
-69.10M
Average
-64.27M
Median
Sep 2021
Free Cash Flow Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -34.18M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.408M |
| ESSA Pharma Inc | -22.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.46M |
| Cash from Investing (Quarterly) | -239.73M |
| Cash from Financing (Quarterly) | 324.01M |
| Free Cash Flow Per Share (Quarterly) | -0.508 |
| Free Cash Flow Yield | -5.16% |